Stockreport

AEON Biopharma, Inc. Announces Reverse Stock Split

AEON Biopharma, Inc. Class A  (AEON) 
PDF IRVINE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a [Read more]